Drugs / Afluria® Quadrivalent
Afluria® Quadrivalent
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT05330975 | Apr 2022 → Nov 2024 | respiratory syncytial virus infectious disease | ModernaTX, Inc. | Completed | Mixed |
| Phase 3 | NCT02914275 | Sep 2016 → Mar 2017 | influenza | Seqirus | Completed | Met primary |
Evidence & citations 7 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Afluria Quadrivalent | “A staged clinical development program of a quadrivalent vaccine (Seqirus IIV4 [S-IIV4]; Afluria® Quadrivalent/Afluria Quad™/Afluria Tetra™), wherein each vaccine strain is...” PMID 30057283 ↗ Jul 2018 |
| Known as | Afluria Quad | “A staged clinical development program of a quadrivalent vaccine (Seqirus IIV4 [S-IIV4]; Afluria® Quadrivalent/Afluria Quad™/Afluria Tetra™), wherein each vaccine strain is...” PMID 30057283 ↗ Jul 2018 |
| Known as | Afluria Tetra | “A staged clinical development program of a quadrivalent vaccine (Seqirus IIV4 [S-IIV4]; Afluria® Quadrivalent/Afluria Quad™/Afluria Tetra™), wherein each vaccine strain is...” PMID 30057283 ↗ Jul 2018 |
| Known as | S-IIV4 | “A staged clinical development program of a quadrivalent vaccine (Seqirus IIV4 [S-IIV4]; Afluria® Quadrivalent/Afluria Quad™/Afluria Tetra™), wherein each vaccine strain is...” PMID 30057283 ↗ Jul 2018 |
| Known as | Seqirus IIV4 | “A staged clinical development program of a quadrivalent vaccine (Seqirus IIV4 [S-IIV4]; Afluria® Quadrivalent/Afluria Quad™/Afluria Tetra™), wherein each vaccine strain is...” PMID 30057283 ↗ Jul 2018 |
| Modality | Vaccine | “A staged clinical development program of a quadrivalent vaccine” PMID 30057283 ↗ Jul 2018 |
| Route | Intramuscular | “Preferred sites for intramuscular injection are the anterolateral aspect of the thigh in infants 6 months through 11 months of age, the anterolateral aspect of the thigh (or...” NCT02914275 ↗ |